Published: Jan 04, 2021
MARLBOROUGH, Mass., Jan. 4, 2021 /PRNewswire/ Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer s disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company s new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix s Chief Financial Officer (CFO).
Dr. Sadowsky is nationally renowned physician and researcher in AD and neurodegenerative diseases. He is a Clinical Professor of Neurology at Nova SE University and was the Founding Director of Research at the Palm Beach Neurology and Premiere Research Institute in West Palm Beach, Florida, a nationally recognized clinical research group focused on AD. Among his notable successes, Dr. Sadowsky has conducted over 300 Alzheimer s clinical trials, including the amyloid PET Amyvid trial and the IDEAS trial. He served on the scientific review board for Alzheimer s Drug Discovery Foundations (A